Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05099835Completed
Randomised trial of botulinum toxin type A in Bell's palsy (2 arms), sponsored by Assiut University. Primary endpoint: Change from Baseline House-Brackmann Score at 3 months. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05099835.